Vaginal progesterone to reduce the rate of preterm birth and neonatal morbidity: a solution at last

ISSN： 1745-5057

Source： Women's Health, Vol.7, Iss.5, 2011-09, pp. : 501-504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Progesterone: Indications for the Prevention of Preterm Birth

Current Women's Health Reviews, Vol. 8, Iss. 4, 2012-01 ,pp. : 312-325

Bentham Science Publishers

Access to resources Recommend Favorite

Progesterone/Progestagens to Prevent Preterm Birth: When and How

Current Women's Health Reviews, Vol. 2, Iss. 3, 2006-08 ,pp. : 165-171

Bentham Science Publishers

Access to resources Recommend Favorite

The rationale for use of progesterone in the prevention of preterm birth?

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 122, Iss. 13, 2015-12 ,pp. : 1808-1808

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomised controlled double‐blind clinical trial of 17‐hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 122, Iss. 1, 2015-01 ,pp. : 71-79

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta‐analysis including data from the OPPTIMUM study

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol. 48, Iss. 3, 2016-09 ,pp. : 308-317

John Wiley & Sons Inc

Access to resources Recommend Favorite